Skip to main content

Advertisement

Table 3 Comparison of classifier scores in patients who reached an endpoint compared to those who did not

From: Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria

Endpoint Yes No p value
30% decline eGFR (29 events) 0.239 ± 0.414 0.228 ± 0.390 0.886
Transition micro to macroalbuminuria (19 events) 0.354 ± 0.238 0.145 ± 0.406 *0.036
Cardiovascular event (31 events) 0.331 ± 0.389 0.216 ± 0.405 0.156
Mortality (20 events) 0.438 ± 0.355 0.208 ± 0.403 *0.017
  1. We defined the following endpoints for analysis: (1) All-cause mortality. (2) CV events. (3) 30% decline in eGFR. (4) Transition from micro to macroalbuminuria. With regard to the latter, there were 19 patients who progressed and 73 who remained microalbuminuric or regressed; we did not analyse data on people who were macroalbuminuric at baseline. Data are mean ± SD, p value of < 0.05 deemed statistically significant. Comparisons are by 2 sample t test. p < 0.05 and * denote statistical significance